Centessa Pharmaceuticals (CNTA) Net Margin (2022 - 2025)
Historic Net Margin for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q1 2025 value amounting to 174.23%.
- Centessa Pharmaceuticals' Net Margin changed N/A to 174.23% in Q1 2025 from the same period last year, while for Sep 2025 it was 1617.99%, marking a year-over-year decrease of 78928900.0%. This contributed to the annual value of 2204.65% for FY2023, which is N/A changed from last year.
- Latest data reveals that Centessa Pharmaceuticals reported Net Margin of 174.23% as of Q1 2025.
- In the past 5 years, Centessa Pharmaceuticals' Net Margin ranged from a high of 3911.74% in Q2 2022 and a low of 174.23% during Q1 2025
- Its 3-year average for Net Margin is 2029.58%, with a median of 1959.74% in 2022.
- Examining YoY changes over the last 5 years, Centessa Pharmaceuticals' Net Margin showed a top increase of -5263900bps in 2023 and a maximum decrease of -28959800bps in 2023.
- Over the past 3 years, Centessa Pharmaceuticals' Net Margin (Quarter) stood at 1959.74% in 2022, then dropped by -27bps to 1433.35% in 2023, then crashed by -112bps to 174.23% in 2025.
- Its Net Margin was 174.23% in Q1 2025, compared to 1433.35% in Q4 2023 and 1520.98% in Q3 2023.